These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 19609618)
1. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue. Chung MK; Jeong HS; Son YI; So YK; Park GY; Choi JY; Hyun SH; Kim HJ; Ko YH; Baek CH Ann Surg Oncol; 2009 Nov; 16(11):3111-7. PubMed ID: 19609618 [TBL] [Abstract][Full Text] [Related]
2. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Chung MK; Jeong HS; Park SG; Jang JY; Son YI; Choi JY; Hyun SH; Park K; Ahn MJ; Ahn YC; Kim HJ; Ko YH; Baek CH Clin Cancer Res; 2009 Sep; 15(18):5861-8. PubMed ID: 19737951 [TBL] [Abstract][Full Text] [Related]
3. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma. Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. Liao S; Penney BC; Zhang H; Suzuki K; Pu Y Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
6. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus. Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization. Piduru SM; Schuster DM; Barron BJ; Dhanasekaran R; Lawson DH; Kim HS J Vasc Interv Radiol; 2012 Jul; 23(7):943-8. PubMed ID: 22609292 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT. Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma. Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574 [TBL] [Abstract][Full Text] [Related]
11. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma. Ma BB; King A; Lo YM; Yau YY; Zee B; Hui EP; Leung SF; Mo F; Kam MK; Ahuja A; Kwan WH; Chan AT Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):714-20. PubMed ID: 17011447 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer. Chung HH; Kwon HW; Kang KW; Park NH; Song YS; Chung JK; Kang SB; Kim JW Ann Surg Oncol; 2012 Jun; 19(6):1966-72. PubMed ID: 22124757 [TBL] [Abstract][Full Text] [Related]
13. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx. Kim MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Eur J Surg Oncol; 2007 Jun; 33(5):633-8. PubMed ID: 17391904 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392 [TBL] [Abstract][Full Text] [Related]
16. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue]. Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277 [TBL] [Abstract][Full Text] [Related]
17. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Basu D; Siegel BA; McDonald DJ; Nussenbaum B Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. Dibble EH; Alvarez AC; Truong MT; Mercier G; Cook EF; Subramaniam RM J Nucl Med; 2012 May; 53(5):709-15. PubMed ID: 22492732 [TBL] [Abstract][Full Text] [Related]
20. [Multivariate analysis for prognostic predictors in the cN0 squamous cell carcinoma of the tongue]. Zhao H; Zeng ZY; Chen FJ; Xu GP; Wu GH; Guo ZM; Zhang Q Ai Zheng; 2003 Feb; 22(2):206-9. PubMed ID: 12600302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]